Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susan M. Chang, MD
University of California, San Francisco
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Hillman Cancer Center at University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- M.D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2003
- Primary completion
- 6 Oct 2007
- Completion
- 2 Jan 2009
- Last update posted
- 21 Aug 2018
- Registered enrollment
- 55
- Registry id
- NCT00058123
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.